Live Breaking News & Updates on அதே குழு|Page 7

Stay updated with breaking news from அதே குழு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Kintor Pharmaceutical Announces Results from Investigator-Initiated Brazil Trial Demonstrating 92% Reduction in Mortality in Hospitalized COVID-19 Patients


Share this article
Share this article
SUZHOU, China, March 11, 2021 /PRNewswire/ Kintor Pharmaceutical Limited (HKEX: 9939), a clinical-stage biotechnology company developing small molecule and biological therapeutics, announced today top-line results from its investigator-initiated Brazil trial evaluating the efficacy of Proxalutamide relative to standard of care as assessed by the COVID-19 ordinal scale. In the clinical trial, Proxalutamide met the primary endpoint at day 14, demonstrating a reduction of 4.01 in WHO COVID-19 ordinal scale from a baseline of 5.663 to 1.653 in the Proxalutamide arm versus a reduction of 0.25 from a baseline of 5.618 to 5.368 in the control arm with a p value 0.0001. Proxalutamide also demonstrated a reduction in mortality risk by 92% (3.7% vs 47.6%) and shortened median hospital length stayby 9 days (median hospital stay of 5 days vs 14 days). ....

Andy Goren , Karl Schmieder , Adsuara Cadegiani , Kintor Pharmaceuticals , Ir Team , Pr Team , We At Kintor Pharmaceuticals , Samel Group , Prnewswire Kintor Pharmaceutical Limited , Pharmaceutical Limited , Tong Youzhi , Chief Executive Officer , Kintor Pharmaceutical , Intensive Care Units , North Brazil , ஆண்டி கோரேன் , ஈர் அணி , ப்ர் அணி , அதே குழு , மருந்து வரையறுக்கப்பட்டவை , தலைமை நிர்வாகி அதிகாரி , தீவிர பராமரிப்பு அலகுகள் , வடக்கு பிரேசில் ,